Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peptikol EasyGraft
- Development stage
- Unknown
- Lead developer
- NIBEC
- Modality
- Peptides
- Administration
- Implant
01
Overview
Peptikol EasyGraft (also known as PeptiCol EZgraft) is a photoresponsive peptide-based tissue regeneration inducer and combination medical device developed by NIBEC. It is designed for dental bone regeneration and periodontal tissue regeneration, particularly for extraction socket preservation procedures after tooth extraction. The device combines high-purity collagen, functional active substances, and regenerative functional peptides within a photoreactive collagen gel. It utilizes light as a catalyst to enhance the release and structural stability of the peptides, promoting bone regeneration and suppressing periodontitis without requiring chemical crosslinking agents. A specific formulation, PeptiCol-EZgraft Oss, which combines the xenogeneic bone graft material OssGen-X15 with the light-responsive collagen gel, has been approved by South Korea's Ministry of Food and Drug Safety (MFDS).
- Brand names
- PeptiCol-EZgraft OssPeptikol EasyGraft
- Other names
- PeptiCol EZgraftPeptiCol-EZgraft펩티콜 이지그라프트펩티콜 이지그라프트 오스
02
Targets
COL1 (Collagen type I)Neuraminidase
Beyond the preview
Go deeper on Peptikol EasyGraft.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Peptikol EasyGraft.